PURPOSE: The Florida Initiative for Quality Cancer Care (FIQCC) was established to evaluate the quality of cancer care at the regional level across the state of Florida. This study assessed adherence to validated quality indicators in colorectal cancer (CRC) and the variability in adherence by practice site, volume, and patient age. METHODS: The FIQCC is a consortium of 11 medical oncology practices in Florida. Medical record reviews were conducted for 507 patients diagnosed with CRC and seen as new medical oncology patients in 2006. Thirty-five indicators were evaluated individually and categorized across clinical domains and components of care. RESULTS: The mean adherence for 19 of 35 individual indicators was > 85%. Pathology reports were compliant on reporting depth of tumor invasion (96%; range, 86% to 100%), grade (93%; range, 72% to 100%), and status of proximal and distal surgical resection margins (97%; range. 86% to 100%); however, documentation of lymphovascular and perineural invasion did not meet adherence standards (76%; range, 53% to 100% and 39%; range, 5% to 83%, respectively). Among patients with nonmetastatic rectal cancer, documentation of the status of surgical radial margins was consistently low across sites (42%; range, 0% to 100%; P = .19). Documentation of planned treatment regimens for adjuvant chemotherapy was noted in only 58% of eligible patients. CONCLUSION: In this large regional initiative, we found high levels of adherence to more than half of the established quality indicators. Although the quality of care delivered within FIQCC practices seems to be high, several components of care were identified that warrant further scrutiny on both a systemic level and at individual centers.
PURPOSE: The Florida Initiative for Quality Cancer Care (FIQCC) was established to evaluate the quality of cancer care at the regional level across the state of Florida. This study assessed adherence to validated quality indicators in colorectal cancer (CRC) and the variability in adherence by practice site, volume, and patient age. METHODS: The FIQCC is a consortium of 11 medical oncology practices in Florida. Medical record reviews were conducted for 507 patients diagnosed with CRC and seen as new medical oncology patients in 2006. Thirty-five indicators were evaluated individually and categorized across clinical domains and components of care. RESULTS: The mean adherence for 19 of 35 individual indicators was > 85%. Pathology reports were compliant on reporting depth of tumor invasion (96%; range, 86% to 100%), grade (93%; range, 72% to 100%), and status of proximal and distal surgical resection margins (97%; range. 86% to 100%); however, documentation of lymphovascular and perineural invasion did not meet adherence standards (76%; range, 53% to 100% and 39%; range, 5% to 83%, respectively). Among patients with nonmetastatic rectal cancer, documentation of the status of surgical radial margins was consistently low across sites (42%; range, 0% to 100%; P = .19). Documentation of planned treatment regimens for adjuvant chemotherapy was noted in only 58% of eligible patients. CONCLUSION: In this large regional initiative, we found high levels of adherence to more than half of the established quality indicators. Although the quality of care delivered within FIQCC practices seems to be high, several components of care were identified that warrant further scrutiny on both a systemic level and at individual centers.
Authors: Paul B Jacobsen; David Shibata; Erin M Siegel; Ji-Hyun Lee; William J Fulp; Carlos Alemany; Guillermo Abesada-Terk; Richard Brown; Thomas Cartwright; Douglas Faig; George Kim; Richard Levine; Merry-Jennifer Markham; Fred Schreiber; Philip Sharp; Mokenge Malafa Journal: Psychooncology Date: 2010-09-27 Impact factor: 3.894
Authors: Michael N Neuss; Christopher E Desch; Kristen K McNiff; Peter D Eisenberg; Dean H Gesme; Joseph O Jacobson; Mohammad Jahanzeb; Jennifer J Padberg; John M Rainey; Jeff J Guo; Joseph V Simone Journal: J Clin Oncol Date: 2005-08-08 Impact factor: 44.544
Authors: Michael O Idowu; Leonas G Bekeris; Stephen Raab; Stephen G Ruby; Raouf E Nakhleh Journal: Arch Pathol Lab Med Date: 2010-07 Impact factor: 5.534
Authors: C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett Journal: Arch Pathol Lab Med Date: 2000-07 Impact factor: 5.534
Authors: Paul B Jacobsen; David Shibata; Erin M Siegel; Mihaela Druta; Ji-Hyun Lee; Jan Marshburn; Linda Davenport; Hugh Cruse; Richard Levine; Avantica Gondi; Richard Brown; Mokenge Malafa Journal: J Oncol Pract Date: 2007-03 Impact factor: 3.840
Authors: Dorothy Romanus; Martin R Weiser; John M Skibber; Anna Ter Veer; Joyce C Niland; John L Wilson; Ashwani Rajput; Yu-Ning Wong; Al B Benson; Stephen Shibata; Deborah Schrag Journal: J Natl Compr Canc Netw Date: 2009-09 Impact factor: 11.908
Authors: Paul B Jacobsen; David Shibata; Erin M Siegel; Ji-Hyun Lee; Carlos A Alemany; Richard Brown; Thomas H Cartwright; Richard M Levine; Jesusa Corazon R Smith; Guillermo Abesada-Terk; Mokenge P Malafa Journal: Cancer Control Date: 2009-10 Impact factor: 3.302
Authors: Christine Laronga; Jhanelle E Gray; Erin M Siegel; Ji-Hyun Lee; William J Fulp; Michelle Fletcher; Fred Schreiber; Richard Brown; Richard Levine; Thomas Cartwright; Guillermo Abesada-Terk; George Kim; Carlos Alemany; Douglas Faig; Phillip Sharp; Merry-Jennifer Markham; David Shibata; Mokenge Malafa; Paul B Jacobsen Journal: J Am Coll Surg Date: 2014-07-01 Impact factor: 6.113
Authors: Erin M Siegel; Paul B Jacobsen; Ji-Hyun Lee; Mokenge Malafa; William Fulp; Michelle Fletcher; Jesusa Corazon R Smith; Richard Brown; Richard Levine; Thomas Cartwright; Guillermo Abesada-Terk; George Kim; Carlos Alemany; Douglas Faig; Philip Sharp; Merry-Jennifer Markham; David Shibata Journal: J Am Coll Surg Date: 2013-11-23 Impact factor: 6.113